MMR vaccine (Berna Biotech)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMMR vaccine (Berna Biotech)
Drug Alias NameMeasles-mumps-rubella-vaccine-Berna Biotech
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRubellaMumpsMeasles
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBerna Biotech Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBerna Biotech Ltd
Active IndicationsN/A
Inactive IndicationsRubellaMumpsMeasles

Other Information

ATC CodeN/A
Related LinksWikipedia